Research Topics
| M B LeonSummaryAffiliation: Cardiovascular Research Foundation Country: USA Publications
| Collaborators
|
Detail Information
Publications
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research ConsortiumMartin B Leon
Columbia University Medical Center, New York, New York 10032, USA
J Am Coll Cardiol 57:253-69. 2011..To make these consensus definitions accessible to all stakeholders in TAVI clinical research through a peer reviewed publication, on behalf of the public health...
A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trialMartin B Leon
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
J Am Coll Cardiol 55:543-54. 2010....
Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectivesMartin B Leon
Columbia University Medical Center, New York, NY 10032, USA
Semin Thorac Cardiovasc Surg 18:165-74. 2006....
Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven eventsMartin B Leon
Center for Interventional Vascular Therapy, Columbia University Medical Center, Herbert Irving Pavilion, New York, NY 10032, USA
JACC Cardiovasc Interv 2:504-12. 2009....
Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Martin B Leon
Columbia University Medical Center, New York, New York 10032, USA
JACC Cardiovasc Interv 3:1043-50. 2010..The increased frequency of very late (>1 year) stent thrombosis (VLST) has raised concerns with regard to the safety of sirolimus-eluting stents and paclitaxel-eluting stents (PES)...
Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stentingM B Leon
Cardiovascular Research Foundation, Lenox Hill Hospital, New York, NY 10021, USA
N Engl J Med 344:250-6. 2001..We report on a multicenter, double-blind, randomized trial of intracoronary radiation therapy for the treatment of in-stent restenosis...
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic EndMartin B Leon
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10032, USA
JACC Cardiovasc Interv 2:1208-18. 2009..The aim of this study was to assess, after 2 years of follow-up, the safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent (ZES) compared with a paclitaxel-eluting stent (PES) in patients with native coronary lesions...
A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary diseaseMartin B Leon
Cardiovascular Research Foundation, Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York 10032, USA
J Am Coll Cardiol 46:1812-9. 2005..This study was a randomized, patient- and evaluator-blinded, placebo-controlled trial in patients treated using percutaneous myocardial laser revascularization...
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research ConsortiumMartin B Leon
Columbia University Medical Center, Center for Interventional Vascular Therapy, 173 Fort Washington Avenue, Heart Center, New York, NY 10032, USA
Eur Heart J 32:205-17. 2011..To make these consensus definitions accessible to all stakeholders in TAVI clinical research through a peer reviewed publication, on behalf of the public health...
Acute and long-term results of treatment of diffuse in-stent restenosis in aortocoronary saphenous vein graftsG Dangas
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 86:777-9, A6. 2000..However, this population has high long-term mortality and frequent need for repeat revascularization...
Transcatheter versus surgical aortic-valve replacement in high-risk patientsCraig R Smith
Columbia University Medical Center New York Presbyterian Hospital, New York, NY 10032, USA
N Engl J Med 364:2187-98. 2011..However, the two procedures have not been compared in a randomized trial involving high-risk patients who are still candidates for surgical replacement...
Influence of gender on early and one-year clinical outcomes after saphenous vein graft stentingJ M Ahmed
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 87:401-5. 2001....
Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stentingG Dangas
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 87:470-2, A7. 2001..At 30-day follow-up, there were trends toward increased subacute thrombosis with A+C compared with A+T (1.3% vs 0.2%, p = 0.10). These results suggest that A+C may have marginally higher subacute stent thrombosis than A+T...
Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term resultsR Mehran
Cardiovascular Research Foundation, 55 E 59th St, New York, NY 10022, USA
Am Heart J 141:610-4. 2001..2-4.7, P =.01). CONCLUSION: Repeat stenting for the treatment of focal ISR had a higher postprocedure creatine kinase myocardial band elevation rate and similar long-term clinical results compared with PTCA alone...
Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomyG Dangas
Knox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, New York, New York 10022, USA
J Endovasc Ther 8:39-43. 2001..To report the results of carotid artery stenting (CAS) in patients considered to have high-risk anatomical characteristics for carotid endarterectomy...
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stentsGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 356:998-1008. 2007..Such studies have been inconclusive because of their insufficient size, the use of historical controls, a limited duration of follow-up, and a lack of access to original source data...
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudyIssam Moussa
Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, 130 East 77th St, 9th Floor, New York, NY 10021, USA
Circulation 109:2273-8. 2004..The purpose of this analysis was to determine the impact of sirolimus-eluting stents on outcomes of diabetic compared with nondiabetic patients...
Intravascular ultrasound-guided renal artery stentingG Dangas
Cardiovascular Research Foundation, New York, New York 10022, USA
J Endovasc Ther 8:238-47. 2001..To evaluate the clinical outcomes of patients undergoing renal artery stenting with intravascular ultrasound (IVUS) guidance and compare measurements between IVUS and angiography...
Evaluation of the acute and chronic safety of the biosense injection catheter system in porcine heartsR Kornowski
Cardiovascular Research Foundation, Washington Hospital Center, Washington, D C 20010, USA
Catheter Cardiovasc Interv 48:447-53; discussion 454-5. 1999..Cathet. Cardiovasc. Intervent. 48:447-453, 1999...
Delivery strategies to achieve therapeutic myocardial angiogenesisR Kornowski
Cardiovascular Research Foundation, Washington Hospital Center, Washington DC 20010, USA
Circulation 101:454-8. 2000..In this article, we review the different modes of administration for therapeutic myocardial angiogenesis therapy...
Update on drug-eluting coronary stentsNicholas N Kipshidze
Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
Expert Rev Cardiovasc Ther 3:953-68. 2005..Recent advances in vascular gene transfer have also demonstrated potential new treatment modalities for cardiovascular disease, particularly in the treatment of vascular restenosis...
Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial)Eugenia Nikolsky
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 95:709-15. 2005..Paclitaxel-eluting stents attenuate the increased risk associated with obesity, such that the intermediate-term prognosis after percutaneous coronary intervention is independent of weight...
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent eraTereza Pucelikova
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
Am J Cardiol 101:63-8. 2008..025). In conclusion, our data show that patients with SVG lesions remain a high-risk subgroup with worse outcomes after percutaneous coronary intervention compared with native vessel disease even in the era of drug-eluting stents...
Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosisYoung Hak Kim
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 101:801-6. 2008..However, bifurcation stenosis remains a significant predictor of unfavorable clinical outcome...
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trialAlexandra J Lansky
Columbia University Medical Center, Department of Cardiology, Cardiovascular Research Foundation, New York, New York 10022, USA
Catheter Cardiovasc Interv 72:917-24. 2008..The aim of this article is to examine whether clopidogrel and ticlopidine treatments produce similar clinical outcomes for patients receiving primary stenting for acute myocardial infarction (AMI)...
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials)Yoshihiro Tsuchiya
The Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 98:464-9. 2006..The EES appears to be effective for treatment of de novo coronary lesions in decreasing neointimal proliferation at 6-month follow-up compared with BMSs, regardless of vessel size...
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgeryMartin B Leon
Columbia University Medical Center NewYork Presbyterian Hospital, New York, NY 10032, USA
N Engl J Med 363:1597-607. 2010..Recently, transcatheter aortic-valve implantation (TAVI) has been suggested as a less invasive treatment for high-risk patients with aortic stenosis...
Photoactivation of vascular iNOS and elevation of cGMP in vivo: possible mechanism for photovasorelaxation and inhibition of restenosis in an atherosclerotic rabbit modelsN Kipshidze
Lenox Hill Heart and Vascular Institute, New York, NY, USA
Photochem Photobiol 72:579-82. 2000..Balloon + laser treatment, however, tended to restore the expression of iNOS. Our study demonstrated that intravascular low dose laser irradiation induces iNOS and elevates vascular cGMP in an in vivo atherosclerotic rabbit model...
Effect of the distal-balloon protection system on microembolization during carotid stentingN Al-Mubarak
Lenox Hill Heart and Vascular Institute, New York, NY, USA
Circulation 104:1999-2002. 2001..The distal-balloon protection system significantly reduced the frequency of MES during CAS, particularly during these 3 phases...
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound studyIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 42:1900-5. 2003..Increased periprocedural CK-MB release appears as a trade-off for optimal stent implantation and lower clinical restenosis...
Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis modelNicholas N Kipshidze
Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
Catheter Cardiovasc Interv 64:389-94. 2005..001). In the porcine coronary model, site-specific systemic delivery of Rapamycin utilizing PGMC resulted in overexpression of p27 and a significant reduction of neointimal formation within the stented segments...
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery diseaseAjay J Kirtane
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
JACC Cardiovasc Interv 2:967-76. 2009..Natick, Massachusetts) in the 477 patients with diabetes mellitus (DM) enrolled in the randomized ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease) trial...
Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protectionDale T Ashby
Lenox Hill Heart and Vascular Institute, New York, New York, USA
J Am Coll Cardiol 41:749-52. 2003..It appears that distal embolic protection may not be necessary during PCI of ISR lesions in degenerated SVGs...
Intravascular ultrasound comparison of the retrograde versus antegrade approach to percutaneous intervention for chronic total coronary occlusionsKenichi Tsujita
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
JACC Cardiovasc Interv 2:846-54. 2009..We sought to evaluate the results of the antegrade versus retrograde chronic total occlusion (CTO) technique with intravascular ultrasound (IVUS) imaging...
Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesionsRicardo A Costa
The Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 98:443-6. 2006..14 +/- 0.45 vs 0.40 +/- 0.41 mm, p = 0.004). In-stent restenosis was 3.9% in the Biolimus stent group versus 7.7% in the control group (p = 0.40). There was no exaggerated hyperplasia at the proximal and/or distal edge of the stent...
Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary interventionEugenia Nikolsky
Cardiovascular Research Foundation, and Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 94:300-5. 2004..Contrast-induced nephropathy was among the independent predictors of a 1-year mortality rate (OR 2.75, p <0.001)...
Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trialJiro Aoki
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
Circulation 119:687-98. 2009..The clinical and angiographic predictors of early (<30 days) stent thrombosis (ST) have not been reported in high-risk patients with acute coronary syndromes...
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validationRoxana Mehran
Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York 10022, USA
J Am Coll Cardiol 44:1393-9. 2004..4% to 55.9% for a low and high risk score, respectively). CONCLUSIONS: The risk of CIN after PCI can be simply assessed using readily available information. This risk score can be used for both clinical and investigational purposes...
Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantationHideo Takebayashi
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
Circulation 110:3430-4. 2004..01 and P<0.01), minimum lumen area (P<0.01 and P<0.01), and IH thickness (P<0.01 and P<0.01). CONCLUSIONS: The number and distribution of stent struts affect the amount of neointima after SES implantation...
Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusionsYi-ming Yang
Columbia University Medical Center and Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, USA
Catheter Cardiovasc Interv 63:462-8. 2004..TIMI 3 flow was achieved in all target vessels after further balloon angioplasty or stenting. The Frontrunner device is a safe and effective tool in the treatment of CTOs from ISR...
Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowingsJiro Aoki
Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY, USA
Am J Cardiol 101:58-62. 2008..In conclusion, the incidence of DES and BMS overlap stenting is rare in daily practice, but this procedure is associated with a high rate of target vessel revascularization...
Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaqueKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 95:355-9. 2005..Plaque rupture morphology is associated with higher periprocedural CK-MB release and worse 1-year clinical outcome in patients treated with coronary stenting...
An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary interventionEugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY 10022, USA
J Invasive Cardiol 19:208-13. 2007..We evaluated short-term prognosis and resource utilization of consecutive patients treated with percutaneous coronary intervention (PCI) as a function of fluoroscopy time...
Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trialsSomjot S Brar
Columbia University Medical Center, New York, NY, USA
EuroIntervention 5:475-84. 2009....
Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery diseaseAlexandra J Lansky
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
J Am Coll Cardiol 45:1180-5. 2005..28 [95% CI 0.11 to 0.74], p = 0.01). CONCLUSIONS: The benefits of the paclitaxel-eluting stent in reducing clinical and angiographic restenosis are generalizable to women...
Frequency and determinants of black holes in sirolimus-eluting stent restenosisJose de Ribamar Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
J Invasive Cardiol 18:348-52. 2006..It occurs earlier and is more severe than typical SES failures...
Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasoundMasashi Kimura
The Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 98:436-42. 2006..Although most ISAs after SES implantation do not resolve completely, the incidence of restenosis or thrombosis is not affected...
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trialGiora Weisz
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10032, USA
J Am Coll Cardiol 47:1350-5. 2006....
Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteriesDale T Ashby
Cardiovascular Research Foundation, Lenox Hill Heart and Vascualr Institute, New York, New York 10022, USA
Am J Cardiol 89:1162-6. 2002..A stenting strategy for proximal LAD stenoses appears to attenuate the differences of clinical restenosis noted after non-stent PCI...
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesionsCostantino O Costantini
Cardiovascular Research Foundation, Lenox Hill Hospital, 55 East 59th Street, 6th Floor, New York, New York, NY 10022, USA
J Am Coll Cardiol 41:1725-31. 2003..Vascular brachytherapy with either gamma or beta sources results in significant and similar reductions in restenosis compared with placebo. Similar benefits after VBT prevail in true aorto-ostial lesions...
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stentsAdriano Caixeta
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
J Am Coll Cardiol 54:894-902. 2009..Five-year clinical follow-up has been scheduled per protocol by the 4 Cypher (Cordis/Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) versus bare-metal stent (BMS) randomized trials...
Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patientsG W Stone
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York City, NY, USA
Circulation 104:642-7. 2001..Large periprocedural infarctions (signified by new Q waves and CPK-MB >8xULN) are powerful determinants of death, whereas lesser degrees of CPK-MB release and specific device use do not adversely affect survival...
Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosisKazuyuki Shirai
Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York 10022, USA
Am J Cardiol 92:1409-13. 2003..In matched lesions, beta and gamma VBT achieved similar reductions in treated segment restenosis and recurrent lesion length compared with placebo...
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound studyKenichi Fujii
Cardiovascular Research Foundation, Columbia University Medical Center, 55 East 59th Street, New York, NY 10022, USA
J Am Coll Cardiol 45:995-8. 2005..03) and a significant residual reference segment stenosis (p = 0.02). CONCLUSIONS: Stent underexpansion and residual reference segment stenosis are associated with stent thrombosis after successful SES implantation...
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trialsJeffrey W Moses
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10032, USA
J Am Coll Cardiol 47:2164-71. 2006....
Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysisRicardo A Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
J Am Coll Cardiol 46:599-605. 2005..CONCLUSIONS: In the majority of bifurcation lesions treated with the crush technique, the smallest minimum stent area appeared at the SB ostium. This may contribute to a higher restenosis rate at this location...
Relation between the degree of procedural anticoagulation and complications after coronary stent implantationDale T Ashby
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:319-22. 2003..High levels of procedural anticoagulation with heparin were found to increase hemorrhagic complications without improving clinical or angiographic outcomes...
Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%Makoto Hirose
Cardiovascular Research Foundation, New York, NY 10021, USA
Am J Cardiol 92:141-5. 2003..7) were similar. Negative remodeling is frequently observed in lesions with intermediate stenosis. This suggests that negative remodeling occurs early in lesion formation...
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study)Issam Moussa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, NY, USA
Am J Cardiol 96:1242-7. 2005..30 and 0.26, respectively). In conclusion, implantation of paclitaxel-eluting stents in patients with de novo coronary lesions significantly reduced restenosis in patients with and without calcified lesions...
Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosisKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10021, USA
Circulation 109:1085-8. 2004..03). A gap between SESs was identified in 3 of 11 recurrences versus 1 of 19 nonrecurrent lesions. CONCLUSIONS: Stent underexpansion is a significant cause of failure after SES implantation treatment of ISR...
Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteriesIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:1171-6. 2003..Therefore, there does not appear to be any "downside" to aggressive stent implantation strategies in small vessels. In contrast, IVUS allows maximization of final lumen dimensions to minimize clinical restenosis...
Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trialCostantino O Costantini
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 91:1261-5. 2003
Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stentsEugenia Nikolsky
Columbia University Medical Center, Center for Interventional Vascular Therapy and the Cardiovascular Research Foundation, New York, NY 10022, USA
Catheter Cardiovasc Interv 71:896-906. 2008..We assessed the outcomes in diabetic patients undergoing percutaneous coronary intervention (PCI) using sirolimus-eluting stents (SES) as a function of treatment with glycoprotein (GP) IIb/IIIa inhibitors...
Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloonJose de Ribamar Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 100:812-7. 2007..In conclusion, in this observational, nonrandomized study, pretreatment with the AngioSculpt balloon enhanced stent expansion and minimized the difference between predicted and achieved stent dimensions...
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial)Jeffrey W Moses
Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
Am J Cardiol 90:243-7. 2002..The relative impact of this treatment is more pronounced in diabetic patients because it appears to neutralize the added risk of recurrent restenosis seen in proliferative diabetic lesions...
Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis modelNicholas N Kipshidze
Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
Catheter Cardiovasc Interv 61:518-27. 2004..In the porcine coronary model, an advanced c-myc-eluting PC stent blocked c-myc expression and significantly inhibited myointimal hyperplasia and allowed complete reendothelialization and healing response...
Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantationHideo Takebayashi
Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 95:498-502. 2005....
Intravascular ultrasound assessment of drug-eluting stent expansionJose de Ribamar Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, NY, USA
Am Heart J 153:297-303. 2007....
The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary interventionAdam J Saltzman
Cardiovascular Medicine and the Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA
J Invasive Cardiol 22:2-6. 2010..We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI)...
Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry)Jie Qian
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 103:1210-4. 2009....
Feasibility and efficacy of tandem positioning on angiographic and clinical outcomes in the Intimal Hyperplasia Inhibition with Beta In-Stent TrialKazuyuki Shirai
Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York 10022, USA
Am J Cardiol 91:1113-5. 2003
Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantationXuebo Liu
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
JACC Cardiovasc Interv 2:997-1004. 2009..We used intravascular ultrasound (IVUS) to assess incidence, predictors, morphology, and angiographic findings of edge dissections after drug-eluting stent (DES) implantation...
Low-power laser irradiation increases cyclic GMP synthesis in penile smooth muscle cells in vitroN Kipshidze
Lenox Hill Heart and Vascular Institute of New York, Cardiovascular Research Foundation, New York, New York 10021, USA
J Clin Laser Med Surg 18:291-4. 2000..The objective of the present study was to determine the effect of low-power laser irradiation (LPLI) on cyclic guanosine monophosphate (cGMP) produced by human corpus cavernosum smooth muscle cells (HCC SMC) in vitro...
Transient contrast encephalopathy after carotid artery stentingG Dangas
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Endovasc Ther 8:111-3. 2001..To report an unusual case of transient contrast encephalopathy arising after carotid artery stenting...
Relation between preintervention remodeling and late arterial responses to coronary angioplasty or atherectomyG S Mintz
Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 87:392-6. 2001..This may explain that the increased clinical restenosis after positive remodeling lesions is treated with non-stent interventions...
Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndromeEduardo Missel
Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY, USA
Am J Cardiol 101:573-8. 2008..01) than patients with no predictors. In conclusion, VH-IVUS analysis showed that the percentage of NC and its ratio to DC in diseased coronary segments are positively associated with a high-risk ACS presentation...
Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary modelGishel New
Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
Catheter Cardiovasc Interv 57:266-71. 2002..Estrogen-coated stents may have a potential benefit in the prevention and treatment of in-stent restenosis...
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarctionCostantino O Costantini
Cardiovascular Research Foundation and Lenox Hill Hospital, New York, New York, USA
J Am Coll Cardiol 44:305-12. 2004..Neither stents nor GP IIb/IIIa inhibitors significantly enhance myocardial perfusion compared to balloon angioplasty alone, underlying the similar long-term mortality with these different mechanical reperfusion strategies...
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)Ricardo A Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
Am J Cardiol 95:113-6. 2005..There was 1 in-stent and 1 in-segment (proximal edge) restenosis in the metallic stent group. There was no stent thrombosis or aneurysm formation at follow-up in either group...
Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapyCostantino O Costantini
Cardiovascular Research Foundation, New York, New York 10021, USA
Am J Cardiol 92:1214-7. 2003....
Gamma radiation for in-stent restenosis: effect of lesion length on angiographic and clinical outcomesRoxana Mehran
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Catheter Cardiovasc Interv 61:354-9. 2004..Lesion length remains a powerful predictor of recurrent ISR and clinical events after treatment of ISR even with gamma-RT...
New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registryAlexandra J Lansky
Cardiac Catheterization Laboratory and the Women s Cardiac Health Initiative, Lenox Hill Hospital, New York City, NY 10022, USA
Epidemiology 13:S46-51. 2002..To gain insight into the outcome of women after new-device angioplasty, we reviewed the early and late clinical outcome of 7,372 patients undergoing new-device angioplasty between 1991 and 1996 at the Washington Hospital Center...
Serial intravascular ultrasound analysis of bifurcation lesions treated using the novel self-expanding sideguard side branch stentHiroshi Doi
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 104:1216-21. 2009..35). In conclusion, serial IVUS analyses of the self-expanding bare metal Sideguard stent indicate preserved SB ostial lumen dimensions at follow-up due to additional increases in stent area that more than compensated for IH...
Association of plaque characterization by intravascular ultrasound virtual histology and arterial remodelingKenichi Fujii
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 96:1476-83. 2005..26, p=0.02). In conclusion, in vivo IVUS radiofrequency data analysis demonstrates that positive remodeling occurs in lesions with more fibrofatty plaque...
Late incomplete lesion coverage following Cypher stent deployment for diffuse right coronary artery stenosisA Halkin
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Heart 90:e45. 2004..A case of stent fracture following percutaneous coronary intervention in which this strategy was used is reported...
Brachytherapy for in-stent restenosis through the internal mammary arteryY Kobayashi
Lenox Hill Heart and Vascular Institute, New York, New York, USA
Catheter Cardiovasc Interv 53:530-4. 2001..After angioplasty, catheter-based gamma radiation was performed. There was no delivery failure of the radiation system. All cases had angiographic success and no procedural or in-hospital complications...
Intra-arterial reteplase for the treatment of acute limb ischemiaJ R Laird
Cardiovascular Research Foundation, 110 Irving Street N W, Suite 4B 1, Washington, D C 20010, USA
J Invasive Cardiol 11:757-62. 1999..We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy...
One-year clinical outcome after minimally invasive direct coronary artery bypassR Mehran
Cardiovascular Research Foundation, New York, NY 10022, USA
Circulation 102:2799-802. 2000..Minimally invasive coronary artery bypass (MIDCAB) is a new surgical technique by which the left internal mammary artery is anastomosed under direct visualization to the left anterior descending artery without cardiopulmonary bypass...
Subarachnoidal hemorrhage following carotid stenting with the distal-balloon protectionN Al-Mubarak
The Lenox Hill Heart and Vascular Institute of New York, New York, NY, USA
Catheter Cardiovasc Interv 54:521-3. 2001..Head CT scan showed massive subarachnoidal hemorrhage contralateral to the stented side and a secondary intracerebral hemorrhage. Despite immediate successful blood pressure control, his condition deteriorated and he died 2 days later...
Effect of short pulsed nonablative infrared laser irradiation on vascular cells in vitro and neointimal hyperplasia in a rabbit balloon injury modelN Kipshidze
Lenox Hill Heart and Vascular Institute of New York and Cardiovascular Research Foundation, New York, NY, USA
Circulation 104:1850-5. 2001..Neointimal hyperplasia after PTCA is an important component of restenosis...
Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine modelsR Kornowski
Cardiovascular Research Foundation, Washington Hospital Center, Washington, DC 20010, USA
J Am Coll Cardiol 35:1031-9. 2000..To test the feasibility of myocardial angiogenic gene expression using a novel catheter-based transendocardial injection system...
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devicesG Dangas
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
J Am Coll Cardiol 38:638-41. 2001..5 vs. 1.5%, p = 0.03). CONCLUSIONS: In this early experience with ACD after PCI, their use was associated with higher vascular complication rates than hemostasis with manual compression...
Echocardiographic assessment of pressure volume relations in heart failure and valvular heart disease: using imaging to understand physiologyP Green
Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY 10034, USA
Minerva Cardioangiol 59:375-89. 2011..This review explores the physiologic background, basic methodology, and recent and potential future applications of noninvasive PV analysis...
Local delivery of c-myc neutrally charged antisense oligonucleotides with transport catheter inhibits myointimal hyperplasia and positively affects vascular remodeling in the rabbit balloon injury modelN Kipshidze
Lenox Hill Heart and Vascular Institute of New York and Cardiovascular Research Foundation, New York, New York 10021, USA
Catheter Cardiovasc Interv 54:247-56. 2001..82 +/- 0.32 mm(2) in the control and antisense delivery groups, respectively (P < 0.05). We conclude that local delivery of Resten-NG inhibited myointimal hyperplasia after PTCA in cholesterol-fed rabbits for up to 60 days...
Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass graftsDonald S Baim
Division of Cardiovascular Diseases, Brigham and Women s Hospital, Boston, Mass 02115, USA
Circulation 105:1285-90. 2002..We report the first multicenter randomized trial to evaluate use of a distal embolic protection device during stenting of such lesions...
Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trialShinjo Sonoda
Center for Research in Cardiovascular Interventions, Stanford University Medical Center, Stanford, California 94305-5637, USA
J Am Coll Cardiol 43:1959-63. 2004..In addition, SES had a considerably lower optimal MSA threshold compared to BMS...
Evolving strategies for the treatment of valvular heart disease: Preclinical and clinical pathways for percutaneous aortic valve replacementJames I Fann
Catheter Cardiovasc Interv 71:434-40. 2008..g., conventional aortic valve replacement, best medical management, and/or balloon valvuloplasty...
Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trialsRainer Hoffmann
Medical Clinic I, University Hospital Aachen, Aachen, Germany
Catheter Cardiovasc Interv 66:499-506. 2005....
Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial)Ryota Sakurai
Center for Research in Cardiovascular Interventions, Stanford University Medical Center, Stanford, California, USA
Am J Cardiol 96:1251-3. 2005..Thus, full lesion coverage and matching the stented segment properly to the adjacent segment using intravascular ultrasound guidance may improve sirolimus-eluting stent implantation efficacy further...
Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantationHideaki Kaneda
The Center for Research in Cardiovascular Interventions, Stanford University, Stanford, California, USA
Am J Cardiol 96:1237-41. 2005..In patients who have coronary artery disease, sirolimus-eluting stents continue to demonstrate striking suppression of neointimal proliferation, irrespective of lesion characteristics previously associated with greater restenotic risk...
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stentsLaura Mauri
Brigham and Women's Hospital, Boston, Massachusetts 02115, USA
Am J Cardiol 95:1140-5. 2005..Longer stent-to-lesion length strategies should be used only when a shorter stent is likely to result in incomplete lesion coverage and edge dissection, a strong determinant of stent thrombosis...
